Browse > Article

Correlation of Clinical Factors with HMGI(Y), p53 and Ki-67 Expression in Squamous Cell Carcinomas of the Head and Neck  

Rho Young-Soo (Department of Otorhinolayngology-Head and Neck Surgery, Hallym University College of Medicine)
Park Jun-Young (Department of Otorhinolayngology-Head and Neck Surgery, Hallym University College of Medicine)
Park Il-Seok (Department of Otorhinolayngology-Head and Neck Surgery, Hallym University College of Medicine)
Lim Young-Chang (Department of Otorhinolayngology-Head and Neck Surgery, Hallym University College of Medicine)
Moon Sung-Ho (Department of Otorhinolayngology-Head and Neck Surgery, Hallym University College of Medicine)
Kim Sung-Dong (Department of Otorhinolayngology-Head and Neck Surgery, Hallym University College of Medicine)
Hwang Joon-Sik (Department of Otorhinolayngology-Head and Neck Surgery, Hallym University College of Medicine)
Kim Duk-Hwan (Department of Pathology, Hallym University College of Medicine)
Publication Information
Korean Journal of Head & Neck Oncology / v.18, no.1, 2002 , pp. 11-17 More about this Journal
Abstract
Objectives: Expression of HMGI(Y), a nucleoprotein that binds to A/T rich sequences in the minor groove of the DNA helix, is observed in neoplastically transformed cells but not in normal cells. We have analyzed HMGI(Y), p53 expression and Ki-67 labelling index in squamous cell carcinomas of the head and neck, and evaluated its clinicopathologic significance. Materials and Methods: 40 cases of squamous cell carcinoma of the head and neck were entered on the study of immunohistochemical stains for HMGI(Y), p53 and Ki-67. We analyzed the relationship between HMGI(Y), p53, Ki-67 expression and age, sex, primary tumor site, stage, survival rate, recurrence. Results: HMGI(Y) expression evidenced by immunohistochemical staining was observed in 35 of 40 (87.5%) squamous cell carcinoma of the head and neck. But no significant correlation was observed between HMGI(Y) expression and other clinical factors such as primary site, tumor stage, differenciation, cervical lymph node, metastasis, recurrence and immunohistochemical status of p53. The Ki-67 labelling index was significantly correlated with recurrence and HMGI(Y) expression (p<0.05). Conclusion: This results suggest the Ki-67 is a good prognostic factor and the HMGI(Y) expression plays some roles in carcinogenesis and cellular proliferation of squamous cell carcinoma of the head and neck. HMGI(Y) gene can be used as a cancer marker, the correlation between the gene expression and the prognosis of the cancer patient should be proved in the future studies.
Keywords
Squamous cell; Carcinoma; High mobility group proteins; Protein p53; Ki-67 Antigen;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Jones AS, Roland NJ, Caslin AW,Cooke TG : A comparison of cellular proliferation markers in squamous cell carcinoma ofthe head and neck. J Laryngol Otol. 1994 ; 108 : 859-864   PUBMED
2 Chiappeta G, Bandiera A, Berlingieri MT, et al : The expression ofthe high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene. 1995 ; 10 : 1307-1314
3 Watling DL, Gown AM, Coltrera MD : Overexpression of p53 in head and neck cancer. Head-Neck. 1992 ; 14 : 437-444   DOI   ScienceOn
4 Kamel OW, Franklin WA, Ringus JC, Meyer JS : Thymindine labeling index and Ki-67 growth fraction in lesions ofthe breast. Amer J Pathol. 1989 ; 134 : 107-113
5 Friedmann M, Holth LT, Zoghbi HY, Reeves R : Organization, inducible expression, and chromosomal localization ofthe human HMGI-I (Y) nonhistone protein gene. Nucleic Acids Res. 1993 : 21 : 4259-4267   DOI   ScienceOn
6 Schoenmakers EF, Wanschura S, Mols R, Bullerdiek J, Van de Yen WJ : Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumors. Nature Genet. 1995 ;10 : 436-444   DOI   ScienceOn
7 VogelsteinB, Fearon ER, Hamilton SR, et al : Genetic alterationsduring colorectal tumor development. N Engl J Med. 1998 ; 319 : 525-532   DOI   ScienceOn
8 Tamimi Y, van der Poe1HG, Karthaus HFM, Debruyne PM, Schalken JA : A retrospective study of high mobility group protein I (Y) as progression markerfor prostate cancer determined by in situ hybridization. Br J Cancer. 1996 ; 74 : 573-578   DOI   PUBMED   ScienceOn
9 Giancotti V, Pani B, Andrea PD, et al : Elevated levels of specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by contransfection with c-myc audpolyoma middle T genes. Embo J. 1987 ; 6 : 1981-1987   PUBMED
10 Rajeswari MR, Singh D, Jain A, Ray R : Elevated levels of high-mobility-group chromosomal proteins, HMGAI, in murine skin carcinoma. Cancer Lett. 2001 ; 173 : 93-99   DOI   ScienceOn
11 Gerdes J, Li L, Schlueter C, et al : Immunohistochemical and molecular biologic characterization ofthe cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67 study. Am J Pathol. 1991 ; 138 : 867-873   PUBMED
12 Gasparini G, Boracchi P, Verderio P : Cell kinetics in human breast cancer .: Comparison between the prognostic value ofthe cytoflurometric S-phase fraction and that ofthe antibodies to Ki67 and PCNA antigens detected by imunocytochemistry. Int J Cancer. 1994 ; 57 : 822-829
13 Zhou X, Benson K, Ashar HR, Chada K : Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature. 1995 ; 376 : 771-774   DOI   ScienceOn
14 Bandiera A, Bonifacio D, Manfiloletti G, et al : Expression of HMG1 (Y) proteins in squamous intraepithlial and invasive lesions ofthe uterine cervix. Cancer Res. 1998 ; 58 : 426-431   PUBMED
15 Levine AJ, Momand J, Finlay CA : The p53 tumor supressor gene. Nature. 1991 ; 351 : 453-456   DOI   ScienceOn
16 Giancotti V, Buratti E, Perissin L, et al : Analysis of the HMGI nuclear protein in mouse neoplastic cells induced by different procedures. Exp Cell Res. 1989 ; 184 : 538-545   DOI   ScienceOn
17 Porschen R, Lohe B, Heg1esKJ, Borchard F : Assessment ofcell proliferation in colorectal carcinoma using the monoclonal antibody Ki-67. Cancer. 1989 ; 63 : 1607-1611   DOI   ScienceOn
18 Hopf NJ, Bremm J, Bohl J, Pemeczky A : Image analysis of proliferating cells in tumors of the human nervous system : an immunohistological study with the monoclonal antibody Ki-67. Neurosurg. 1994 ; 35 : 917-923   DOI   ScienceOn
19 Fedele M, Bandiera A, Chiappetta G, et al : Human colorectal carcinomas express high levels ofhigh mobility group HMG1 (Y) proteins. Cancer Res. 1996 ; 56 : 1896-1901   PUBMED
20 Chiappetta G, Tallini MC, De Biasio G, Manfio1ettiF, MartinezTello FJ, Pentimalli F : Detection of high mobility group I HMGI (Y) proteins in the diagnosis of thyroid tumors : HMGI (Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res. 1998 ; 58 : 4193-4198   PUBMED
21 Kim DH, Park YS, Park CA, Son KC, Nam ES, Shin HS : Expression ofthe HMGI (Y) gene in human colorectal cancer. Int J Cancer. 1999; 84 : 376-380   DOI   ScienceOn
22 Zhou X, Chada K : HMG1family proteins: architectural transcription factors in mammalian development and cancer. Keio J Med. 1998 ; 47 (2) : 73-77   DOI   PUBMED   ScienceOn
23 Giancotti V, Berlingieri MT, Di Fiore PP, Fusco A, Vecchio G, Crane-Robionson C : Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus. Cancer Res. 1985 ; 45 : 6051-6057   PUBMED